BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51357638 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)C)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.24,-31.84,;17.89,-33.34,;16.38,-33.68,;15.71,-35.08,;14.17,-35.08,;13.4,-36.42,;11.86,-36.42,;11.09,-35.08,;9.55,-35.08,;8.78,-36.42,;9.55,-37.75,;11.09,-37.75,;7.24,-36.42,;6.47,-37.75,;7.24,-39.08,;4.93,-37.75,;4.16,-36.42,;4.16,-39.08,;16.38,-36.48,;17.89,-36.82,;19.1,-35.85,;20.44,-36.62,;21.78,-35.85,;21.77,-34.3,;23.1,-33.52,;20.44,-33.54,;19.11,-34.31,)| InChI=1S/C22H34ClN3O/c1-16-15-26(13-11-18-6-7-19(23)14-21(16)18)12-10-17-4-8-20(9-5-17)24-22(27)25(2)3/h6-7,14,16-17,20H,4-5,8-13,15H2,1-3H3,(H,24,27) IDTLNOOYTVGUDL-UHFFFAOYSA-N 50549018 CHEMBL4799863 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1230 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549018&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 162677036 461679358 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51357639 CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)c3cccc(c3Cl)Cl InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28) KPWSJANDNDDRMB-UHFFFAOYSA-N 50443101 Cariprazine::RGH-188::US20250109139, Compound Cariprazine 5-hydroxytryptamine receptor 2A Homo sapiens 19 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50443101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50443101&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 7RU 7VOD 11154555 194940997 DB06016 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51357640 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)C)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.24,-31.84,;17.89,-33.34,;16.38,-33.68,;15.71,-35.08,;14.17,-35.08,;13.4,-36.42,;11.86,-36.42,;11.09,-35.08,;9.55,-35.08,;8.78,-36.42,;9.55,-37.75,;11.09,-37.75,;7.24,-36.42,;6.47,-37.75,;7.24,-39.08,;4.93,-37.75,;4.16,-36.42,;4.16,-39.08,;16.38,-36.48,;17.89,-36.82,;19.1,-35.85,;20.44,-36.62,;21.78,-35.85,;21.77,-34.3,;23.1,-33.52,;20.44,-33.54,;19.11,-34.31,)| InChI=1S/C22H34ClN3O/c1-16-15-26(13-11-18-6-7-19(23)14-21(16)18)12-10-17-4-8-20(9-5-17)24-22(27)25(2)3/h6-7,14,16-17,20H,4-5,8-13,15H2,1-3H3,(H,24,27) IDTLNOOYTVGUDL-UHFFFAOYSA-N 50549018 CHEMBL4799863 5-hydroxytryptamine receptor 2A Homo sapiens 26 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549018&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 162677036 461679358 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51357641 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)CC3(CCCC3)CC2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(78.22,-16.9,;77.88,-18.4,;76.36,-18.74,;75.69,-20.14,;74.15,-20.14,;73.38,-21.48,;71.84,-21.48,;71.07,-20.14,;69.53,-20.14,;68.76,-21.48,;69.53,-22.81,;71.07,-22.81,;67.22,-21.48,;66.46,-22.81,;67.23,-24.15,;64.91,-22.81,;64.15,-21.47,;63.25,-20.22,;61.79,-20.69,;61.78,-22.23,;63.24,-22.71,;64.92,-20.14,;66.46,-20.14,;67.23,-18.81,;76.36,-21.54,;77.87,-21.88,;79.09,-20.91,;80.42,-21.68,;81.76,-20.91,;81.75,-19.36,;83.08,-18.58,;80.42,-18.6,;79.09,-19.37,)| InChI=1S/C28H39ClN2O2/c1-20-19-30(15-11-22-6-7-23(29)16-25(20)22)14-10-21-4-8-24(9-5-21)31-26(32)17-28(18-27(31)33)12-2-3-13-28/h6-7,16,20-21,24H,2-5,8-15,17-19H2,1H3 DTQQYFXMBRLANH-UHFFFAOYSA-N 50549019 CHEMBL4753808 5-hydroxytryptamine receptor 2A Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549019&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 162653991 461679359 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51357642 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccco2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(19.71,-32.34,;19.37,-33.84,;17.85,-34.19,;17.18,-35.59,;15.64,-35.59,;14.87,-36.92,;13.33,-36.92,;12.56,-35.59,;11.02,-35.59,;10.25,-36.92,;11.02,-38.26,;12.56,-38.26,;8.71,-36.92,;7.94,-38.26,;8.71,-39.59,;6.4,-38.26,;5.49,-37.02,;4.03,-37.49,;4.03,-39.03,;5.49,-39.51,;17.85,-36.99,;19.36,-37.33,;20.57,-36.36,;21.91,-37.13,;23.25,-36.36,;23.24,-34.81,;24.57,-34.03,;21.91,-34.04,;20.58,-34.81,)| InChI=1S/C24H31ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h2-3,6-7,14-15,17-18,21H,4-5,8-13,16H2,1H3,(H,26,28) KHPOIBBWMVNTMI-UHFFFAOYSA-N 50549020 CHEMBL4780335 5-hydroxytryptamine receptor 2A Homo sapiens 77 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549020&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 162662985 461679360 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51357643 CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)c3cccc(c3Cl)Cl InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28) KPWSJANDNDDRMB-UHFFFAOYSA-N 50443101 Cariprazine::RGH-188::US20250109139, Compound Cariprazine 5-hydroxytryptamine receptor 1A Homo sapiens 2.6 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50443101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50443101&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 7RU 7VOD 11154555 194940997 DB06016 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357644 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N2CCCC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(48.42,-47.98,;48.08,-49.48,;46.56,-49.83,;45.89,-51.23,;44.36,-51.23,;43.58,-52.56,;42.04,-52.56,;41.28,-51.23,;39.74,-51.23,;38.97,-52.56,;39.74,-53.9,;41.27,-53.9,;37.43,-52.56,;36.66,-53.9,;37.42,-55.23,;35.12,-53.9,;34.2,-52.65,;32.74,-53.13,;32.74,-54.67,;34.2,-55.15,;46.56,-52.63,;48.07,-52.97,;49.29,-52,;50.62,-52.77,;51.96,-52,;51.95,-50.44,;53.28,-49.67,;50.62,-49.68,;49.29,-50.45,)| InChI=1S/C24H36ClN3O/c1-18-17-27(15-11-20-6-7-21(25)16-23(18)20)14-10-19-4-8-22(9-5-19)26-24(29)28-12-2-3-13-28/h6-7,16,18-19,22H,2-5,8-15,17H2,1H3,(H,26,29) ORDRIDLDACAQJO-UHFFFAOYSA-N 50549021 CHEMBL4797996 5-hydroxytryptamine receptor 1A Homo sapiens 5.3 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549021&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162674746 461679361 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357645 CCN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1 |r,wU:7.6,wD:10.10,23.24,(32.92,-39.33,;34.46,-39.33,;35.23,-38,;34.46,-36.67,;36.77,-38,;37.54,-39.33,;37.54,-36.67,;39.08,-36.67,;39.85,-35.33,;41.39,-35.33,;42.16,-36.67,;43.7,-36.67,;44.47,-35.33,;46.01,-35.33,;46.67,-36.73,;48.18,-37.07,;49.4,-36.1,;50.73,-36.87,;52.07,-36.1,;52.07,-34.55,;53.4,-33.77,;50.73,-33.79,;49.4,-34.56,;48.19,-33.59,;48.53,-32.09,;46.68,-33.93,;41.39,-38,;39.85,-38,)| InChI=1S/C23H36ClN3O/c1-4-26(3)23(28)25-21-9-5-18(6-10-21)11-13-27-14-12-19-7-8-20(24)15-22(19)17(2)16-27/h7-8,15,17-18,21H,4-6,9-14,16H2,1-3H3,(H,25,28) HXHYBBJDNMJVBF-UHFFFAOYSA-N 50549022 CHEMBL4750939 5-hydroxytryptamine receptor 1A Homo sapiens 36 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549022&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162652001 461679362 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357646 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)C)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.24,-31.84,;17.89,-33.34,;16.38,-33.68,;15.71,-35.08,;14.17,-35.08,;13.4,-36.42,;11.86,-36.42,;11.09,-35.08,;9.55,-35.08,;8.78,-36.42,;9.55,-37.75,;11.09,-37.75,;7.24,-36.42,;6.47,-37.75,;7.24,-39.08,;4.93,-37.75,;4.16,-36.42,;4.16,-39.08,;16.38,-36.48,;17.89,-36.82,;19.1,-35.85,;20.44,-36.62,;21.78,-35.85,;21.77,-34.3,;23.1,-33.52,;20.44,-33.54,;19.11,-34.31,)| InChI=1S/C22H34ClN3O/c1-16-15-26(13-11-18-6-7-19(23)14-21(16)18)12-10-17-4-8-20(9-5-17)24-22(27)25(2)3/h6-7,14,16-17,20H,4-5,8-13,15H2,1-3H3,(H,24,27) IDTLNOOYTVGUDL-UHFFFAOYSA-N 50549018 CHEMBL4799863 5-hydroxytryptamine receptor 1A Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549018&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162677036 461679358 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357647 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)CC3(CCCC3)CC2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(78.22,-16.9,;77.88,-18.4,;76.36,-18.74,;75.69,-20.14,;74.15,-20.14,;73.38,-21.48,;71.84,-21.48,;71.07,-20.14,;69.53,-20.14,;68.76,-21.48,;69.53,-22.81,;71.07,-22.81,;67.22,-21.48,;66.46,-22.81,;67.23,-24.15,;64.91,-22.81,;64.15,-21.47,;63.25,-20.22,;61.79,-20.69,;61.78,-22.23,;63.24,-22.71,;64.92,-20.14,;66.46,-20.14,;67.23,-18.81,;76.36,-21.54,;77.87,-21.88,;79.09,-20.91,;80.42,-21.68,;81.76,-20.91,;81.75,-19.36,;83.08,-18.58,;80.42,-18.6,;79.09,-19.37,)| InChI=1S/C28H39ClN2O2/c1-20-19-30(15-11-22-6-7-23(29)16-25(20)22)14-10-21-4-8-24(9-5-21)31-26(32)17-28(18-27(31)33)12-2-3-13-28/h6-7,16,20-21,24H,2-5,8-15,17-19H2,1H3 DTQQYFXMBRLANH-UHFFFAOYSA-N 50549019 CHEMBL4753808 5-hydroxytryptamine receptor 1A Homo sapiens 4.3 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549019&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162653991 461679359 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357648 [H][C@]12C[C@]([H])(C=C1)[C@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@]21[H] |r,wU:12.12,3.3,1.0,35.41,7.8,wD:15.16,28.30,c:5,(34.02,-24.69,;34.03,-23.15,;33.26,-21.65,;34.04,-20.05,;34.03,-18.51,;32.7,-20.82,;32.69,-22.37,;35.37,-20.83,;35.36,-19.29,;36.83,-20.36,;37.31,-18.9,;37.73,-21.61,;39.27,-21.61,;40.03,-20.28,;41.57,-20.28,;42.35,-21.61,;43.88,-21.61,;44.65,-20.28,;46.19,-20.28,;46.86,-21.67,;48.37,-22.01,;49.58,-21.05,;50.91,-21.81,;52.25,-21.05,;52.24,-19.5,;53.57,-18.72,;50.91,-18.73,;49.59,-19.51,;48.37,-18.53,;48.71,-17.03,;46.86,-18.88,;41.57,-22.95,;40.03,-22.95,;36.83,-22.86,;37.3,-24.32,;35.36,-22.38,;35.35,-23.93,)| InChI=1S/C28H35ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h4-7,15,17-18,20-21,23,25-26H,2-3,8-14,16H2,1H3 MJWAVTIYFCPJPE-UHFFFAOYSA-N 50549023 CHEMBL4788140 5-hydroxytryptamine receptor 1A Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549023&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162669496 461679363 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357649 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)CCC2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(16.19,-17.03,;15.85,-18.53,;14.33,-18.87,;13.67,-20.28,;12.13,-20.28,;11.36,-21.61,;9.82,-21.61,;9.05,-20.28,;7.51,-20.28,;6.74,-21.61,;7.51,-22.94,;9.05,-22.94,;5.2,-21.61,;4.29,-22.84,;4.76,-24.31,;2.83,-22.37,;2.82,-20.82,;4.29,-20.35,;4.77,-18.89,;14.33,-21.67,;15.84,-22.01,;17.06,-21.04,;18.39,-21.81,;19.73,-21.04,;19.72,-19.49,;21.06,-18.72,;18.39,-18.73,;17.06,-19.5,)| InChI=1S/C23H31ClN2O2/c1-16-15-25(13-11-18-4-5-19(24)14-21(16)18)12-10-17-2-6-20(7-3-17)26-22(27)8-9-23(26)28/h4-5,14,16-17,20H,2-3,6-13,15H2,1H3 ULKPWZSJDGLNAA-UHFFFAOYSA-N 50549024 CHEMBL4779969 5-hydroxytryptamine receptor 1A Homo sapiens 93 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549024&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162662417 461679364 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357650 [H][C@]12CC[C@]([H])(C1)[C@@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@@]21[H] |r,wU:12.12,1.0,4.4,7.8,35.41,wD:15.16,28.30,(63.69,-3.63,;63.7,-5.18,;62.36,-5.95,;62.35,-7.49,;63.69,-8.27,;63.68,-9.82,;62.92,-6.78,;65.02,-7.51,;65.01,-9.05,;66.48,-7.99,;66.96,-9.45,;67.39,-6.74,;68.93,-6.74,;69.69,-5.4,;71.23,-5.41,;72.01,-6.74,;73.54,-6.74,;74.31,-5.41,;75.85,-5.41,;76.52,-6.8,;78.03,-7.14,;79.24,-6.18,;80.57,-6.94,;81.91,-6.17,;81.9,-4.63,;83.23,-3.85,;80.57,-3.86,;79.25,-4.63,;78.03,-3.66,;78.37,-2.16,;76.52,-4.01,;71.23,-8.08,;69.69,-8.08,;66.48,-5.49,;66.97,-4.03,;65.03,-5.96,;65.02,-4.41,)| InChI=1S/C28H37ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h6-7,15,17-18,20-21,23,25-26H,2-5,8-14,16H2,1H3 AIYDXOYEOAYSGJ-UHFFFAOYSA-N 50549025 CHEMBL4784751 5-hydroxytryptamine receptor 1A Homo sapiens 25 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549025&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162665485 461679365 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357651 [H][C@@]12CCCC[C@]1([H])C(=O)N([C@H]1CC[C@H](CCN3CCc4ccc(Cl)cc4[C@@H](C)C3)CC1)C2=O |r,wU:11.11,wD:14.15,27.29,1.0,6.7,(5.01,-4.77,;5.03,-6.31,;3.69,-5.55,;2.35,-6.32,;2.36,-7.87,;3.7,-8.64,;5.03,-7.86,;5.02,-9.4,;6.5,-8.34,;6.97,-9.8,;7.4,-7.1,;8.94,-7.1,;9.71,-5.77,;11.25,-5.77,;12.02,-7.1,;13.56,-7.1,;14.33,-5.77,;15.87,-5.77,;16.53,-7.16,;18.04,-7.5,;19.26,-6.53,;20.59,-7.3,;21.93,-6.53,;21.92,-4.98,;23.25,-4.21,;20.59,-4.22,;19.26,-4.99,;18.05,-4.02,;18.39,-2.52,;16.53,-4.37,;11.25,-8.43,;9.71,-8.43,;6.5,-5.85,;6.98,-4.38,)| InChI=1S/C27H37ClN2O2/c1-18-17-29(15-13-20-8-9-21(28)16-25(18)20)14-12-19-6-10-22(11-7-19)30-26(31)23-4-2-3-5-24(23)27(30)32/h8-9,16,18-19,22-24H,2-7,10-15,17H2,1H3 DGWVDYZYSAQNNO-UHFFFAOYSA-N 50549026 CHEMBL4762024 5-hydroxytryptamine receptor 1A Homo sapiens 6.6 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549026&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162659730 461679366 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357652 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)[C@@H]2CCCN2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,15.15,1.0,(77.28,-47.9,;76.94,-49.41,;75.43,-49.75,;74.76,-51.15,;73.22,-51.15,;72.45,-52.49,;70.91,-52.49,;70.14,-51.15,;68.6,-51.15,;67.83,-52.49,;68.6,-53.82,;70.14,-53.82,;66.29,-52.49,;65.52,-53.82,;66.29,-55.15,;63.98,-53.82,;63.07,-55.07,;61.6,-54.59,;61.6,-53.05,;63.07,-52.58,;75.43,-52.55,;76.94,-52.89,;78.15,-51.92,;79.49,-52.69,;80.82,-51.92,;80.82,-50.37,;82.15,-49.59,;79.48,-49.6,;78.16,-50.38,)| InChI=1S/C24H36ClN3O/c1-17-16-28(14-11-19-6-7-20(25)15-22(17)19)13-10-18-4-8-21(9-5-18)27-24(29)23-3-2-12-26-23/h6-7,15,17-18,21,23,26H,2-5,8-14,16H2,1H3,(H,27,29) XWSSRMXCAFXSRM-UHFFFAOYSA-N 50549027 CHEMBL4741673 5-hydroxytryptamine receptor 1A Homo sapiens 75 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549027&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162646372 461679367 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357653 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)[C@@H]2CCCO2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,15.15,1.0,(48.38,-48.01,;48.04,-49.51,;46.53,-49.86,;45.86,-51.26,;44.32,-51.26,;43.55,-52.59,;42.01,-52.59,;41.24,-51.26,;39.7,-51.26,;38.93,-52.59,;39.7,-53.93,;41.24,-53.93,;37.39,-52.59,;36.62,-53.93,;37.39,-55.26,;35.08,-53.93,;34.17,-55.18,;32.7,-54.7,;32.7,-53.16,;34.17,-52.69,;46.52,-52.66,;48.03,-53,;49.25,-52.03,;50.58,-52.8,;51.92,-52.03,;51.92,-50.48,;53.25,-49.7,;50.58,-49.71,;49.25,-50.48,)| InChI=1S/C24H35ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h6-7,15,17-18,21,23H,2-5,8-14,16H2,1H3,(H,26,28) ZCTLRJWCRUVTOB-UHFFFAOYSA-N 50549028 CHEMBL4745809 5-hydroxytryptamine receptor 1A Homo sapiens 98 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549028&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162647966 461679368 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357654 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(76.35,-32.33,;76,-33.84,;74.49,-34.18,;73.82,-35.58,;72.28,-35.58,;71.51,-36.92,;69.97,-36.92,;69.2,-35.58,;67.66,-35.58,;66.89,-36.92,;67.66,-38.25,;69.2,-38.25,;65.35,-36.92,;64.58,-38.25,;65.35,-39.58,;63.04,-38.25,;61.7,-37.49,;61.7,-39.03,;74.49,-36.98,;76,-37.32,;77.21,-36.35,;78.55,-37.12,;79.88,-36.35,;79.88,-34.8,;81.21,-34.02,;78.54,-34.03,;77.22,-34.81,)| InChI=1S/C23H33ClN2O/c1-16-15-26(13-11-18-6-7-20(24)14-22(16)18)12-10-17-2-8-21(9-3-17)25-23(27)19-4-5-19/h6-7,14,16-17,19,21H,2-5,8-13,15H2,1H3,(H,25,27) NRCRTBZRIJXRCY-UHFFFAOYSA-N 50549029 CHEMBL4756826 5-hydroxytryptamine receptor 1A Homo sapiens 191 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549029&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162655294 461679369 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357655 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccco2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(19.71,-32.34,;19.37,-33.84,;17.85,-34.19,;17.18,-35.59,;15.64,-35.59,;14.87,-36.92,;13.33,-36.92,;12.56,-35.59,;11.02,-35.59,;10.25,-36.92,;11.02,-38.26,;12.56,-38.26,;8.71,-36.92,;7.94,-38.26,;8.71,-39.59,;6.4,-38.26,;5.49,-37.02,;4.03,-37.49,;4.03,-39.03,;5.49,-39.51,;17.85,-36.99,;19.36,-37.33,;20.57,-36.36,;21.91,-37.13,;23.25,-36.36,;23.24,-34.81,;24.57,-34.03,;21.91,-34.04,;20.58,-34.81,)| InChI=1S/C24H31ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h2-3,6-7,14-15,17-18,21H,4-5,8-13,16H2,1H3,(H,26,28) KHPOIBBWMVNTMI-UHFFFAOYSA-N 50549020 CHEMBL4780335 5-hydroxytryptamine receptor 1A Homo sapiens 97 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549020&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 162662985 461679360 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51357656 CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)c3cccc(c3Cl)Cl InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28) KPWSJANDNDDRMB-UHFFFAOYSA-N 50443101 Cariprazine::RGH-188::US20250109139, Compound Cariprazine D(3) dopamine receptor Homo sapiens 0.085000 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50443101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50443101&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 7RU 7VOD 11154555 194940997 DB06016 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357657 C[C@@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)C)CCc2ccc(Cl)cc12 |r,wU:9.12,1.0,wD:6.5,(76.3,-2.9,;75.95,-4.4,;74.44,-4.74,;73.77,-6.14,;72.23,-6.14,;71.46,-7.48,;69.92,-7.48,;69.15,-6.14,;67.61,-6.14,;66.84,-7.48,;67.61,-8.81,;69.15,-8.81,;65.3,-7.48,;64.53,-8.81,;65.3,-10.14,;62.99,-8.81,;62.22,-7.48,;62.22,-10.14,;74.44,-7.54,;75.95,-7.88,;77.16,-6.91,;78.5,-7.68,;79.83,-6.91,;79.83,-5.36,;81.16,-4.58,;78.49,-4.6,;77.17,-5.37,)| InChI=1S/C22H34ClN3O/c1-16-15-26(13-11-18-6-7-19(23)14-21(16)18)12-10-17-4-8-20(9-5-17)24-22(27)25(2)3/h6-7,14,16-17,20H,4-5,8-13,15H2,1-3H3,(H,24,27) IDTLNOOYTVGUDL-UHFFFAOYSA-N 50549030 CHEMBL4779912 D(3) dopamine receptor Homo sapiens 195 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549030&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162663054 461679370 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357658 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)c2ccccc2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.74,-2.02,;18.39,-3.52,;16.88,-3.86,;16.21,-5.27,;14.67,-5.27,;13.9,-6.6,;12.36,-6.6,;11.59,-5.27,;10.05,-5.26,;9.28,-6.6,;10.05,-7.93,;11.59,-7.93,;7.74,-6.6,;6.97,-7.93,;7.74,-9.27,;5.43,-7.93,;4.66,-6.6,;4.66,-9.27,;3.12,-9.26,;2.35,-10.59,;3.12,-11.93,;4.67,-11.92,;5.43,-10.59,;16.88,-6.66,;18.39,-7,;19.6,-6.03,;20.94,-6.8,;22.27,-6.03,;22.27,-4.48,;23.6,-3.71,;20.93,-3.72,;19.61,-4.49,)| InChI=1S/C27H36ClN3O/c1-20-19-31(17-15-22-10-11-23(28)18-26(20)22)16-14-21-8-12-24(13-9-21)29-27(32)30(2)25-6-4-3-5-7-25/h3-7,10-11,18,20-21,24H,8-9,12-17,19H2,1-2H3,(H,29,32) KAXUQVAHOIHHMX-UHFFFAOYSA-N 50549031 CHEMBL4755563 D(3) dopamine receptor Homo sapiens 17 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549031&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162655913 461679371 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357659 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)Nc2ccccc2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(80.06,-46.54,;79.71,-48.04,;78.2,-48.38,;77.53,-49.79,;75.99,-49.79,;75.22,-51.12,;73.68,-51.12,;72.91,-49.78,;71.37,-49.78,;70.6,-51.12,;71.37,-52.45,;72.91,-52.45,;69.06,-51.12,;68.29,-52.45,;69.06,-53.79,;66.75,-52.45,;65.98,-53.79,;64.44,-53.78,;63.67,-55.11,;64.44,-56.45,;65.99,-56.44,;66.75,-55.11,;78.2,-51.18,;79.71,-51.52,;80.92,-50.55,;82.26,-51.32,;83.59,-50.55,;83.59,-49,;84.92,-48.23,;82.25,-48.24,;80.93,-49.01,)| InChI=1S/C26H34ClN3O/c1-19-18-30(16-14-21-9-10-22(27)17-25(19)21)15-13-20-7-11-24(12-8-20)29-26(31)28-23-5-3-2-4-6-23/h2-6,9-10,17,19-20,24H,7-8,11-16,18H2,1H3,(H2,28,29,31) DCIOHCJFMCIMPE-UHFFFAOYSA-N 50549032 CHEMBL4759975 D(3) dopamine receptor Homo sapiens 1.5 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549032&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162658416 461679372 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357660 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N2CCCC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(48.42,-47.98,;48.08,-49.48,;46.56,-49.83,;45.89,-51.23,;44.36,-51.23,;43.58,-52.56,;42.04,-52.56,;41.28,-51.23,;39.74,-51.23,;38.97,-52.56,;39.74,-53.9,;41.27,-53.9,;37.43,-52.56,;36.66,-53.9,;37.42,-55.23,;35.12,-53.9,;34.2,-52.65,;32.74,-53.13,;32.74,-54.67,;34.2,-55.15,;46.56,-52.63,;48.07,-52.97,;49.29,-52,;50.62,-52.77,;51.96,-52,;51.95,-50.44,;53.28,-49.67,;50.62,-49.68,;49.29,-50.45,)| InChI=1S/C24H36ClN3O/c1-18-17-27(15-11-20-6-7-21(25)16-23(18)20)14-10-19-4-8-22(9-5-19)26-24(29)28-12-2-3-13-28/h6-7,16,18-19,22H,2-5,8-15,17H2,1H3,(H,26,29) ORDRIDLDACAQJO-UHFFFAOYSA-N 50549021 CHEMBL4797996 D(3) dopamine receptor Homo sapiens 1.1 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549021&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162674746 461679361 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357661 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N2CCOCC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.81,-48,;18.47,-49.5,;16.96,-49.85,;16.29,-51.25,;14.75,-51.25,;13.98,-52.58,;12.44,-52.58,;11.67,-51.25,;10.13,-51.25,;9.36,-52.58,;10.13,-53.91,;11.67,-53.91,;7.82,-52.58,;7.05,-53.91,;7.82,-55.25,;5.51,-53.91,;4.74,-55.25,;3.2,-55.25,;2.43,-53.91,;3.2,-52.58,;4.74,-52.58,;16.95,-52.64,;18.47,-52.98,;19.68,-52.01,;21.01,-52.78,;22.35,-52.01,;22.35,-50.46,;23.68,-49.69,;21.01,-49.7,;19.69,-50.47,)| InChI=1S/C24H36ClN3O2/c1-18-17-27(11-9-20-4-5-21(25)16-23(18)20)10-8-19-2-6-22(7-3-19)26-24(29)28-12-14-30-15-13-28/h4-5,16,18-19,22H,2-3,6-15,17H2,1H3,(H,26,29) UNEYERITNKRLJR-UHFFFAOYSA-N 50549033 CHEMBL4741702 D(3) dopamine receptor Homo sapiens 1.8 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549033&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162646791 461679373 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357662 CCN(CC)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1 |r,wU:8.7,wD:11.11,24.25,(63.55,-38.58,;65.09,-38.58,;65.86,-37.25,;65.09,-35.91,;63.55,-35.91,;67.4,-37.25,;68.17,-38.58,;68.17,-35.91,;69.71,-35.91,;70.48,-34.58,;72.02,-34.58,;72.79,-35.91,;74.33,-35.91,;75.1,-34.58,;76.64,-34.58,;77.31,-35.98,;78.82,-36.32,;80.04,-35.35,;81.37,-36.12,;82.71,-35.35,;82.7,-33.79,;84.03,-33.02,;81.37,-33.03,;80.04,-33.8,;78.83,-32.83,;79.17,-31.33,;77.31,-33.18,;72.02,-37.25,;70.48,-37.25,)| InChI=1S/C24H38ClN3O/c1-4-28(5-2)24(29)26-22-10-6-19(7-11-22)12-14-27-15-13-20-8-9-21(25)16-23(20)18(3)17-27/h8-9,16,18-19,22H,4-7,10-15,17H2,1-3H3,(H,26,29) CRTXNNNIYVQHEB-UHFFFAOYSA-N 50549034 CHEMBL4743651 D(3) dopamine receptor Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549034&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162645987 461679374 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357663 CCN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1 |r,wU:7.6,wD:10.10,23.24,(32.92,-39.33,;34.46,-39.33,;35.23,-38,;34.46,-36.67,;36.77,-38,;37.54,-39.33,;37.54,-36.67,;39.08,-36.67,;39.85,-35.33,;41.39,-35.33,;42.16,-36.67,;43.7,-36.67,;44.47,-35.33,;46.01,-35.33,;46.67,-36.73,;48.18,-37.07,;49.4,-36.1,;50.73,-36.87,;52.07,-36.1,;52.07,-34.55,;53.4,-33.77,;50.73,-33.79,;49.4,-34.56,;48.19,-33.59,;48.53,-32.09,;46.68,-33.93,;41.39,-38,;39.85,-38,)| InChI=1S/C23H36ClN3O/c1-4-26(3)23(28)25-21-9-5-18(6-10-21)11-13-27-14-12-19-7-8-20(24)15-22(19)17(2)16-27/h7-8,15,17-18,21H,4-6,9-14,16H2,1-3H3,(H,25,28) HXHYBBJDNMJVBF-UHFFFAOYSA-N 50549022 CHEMBL4750939 D(3) dopamine receptor Homo sapiens 7.2 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549022&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162652001 461679362 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357664 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)C)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.24,-31.84,;17.89,-33.34,;16.38,-33.68,;15.71,-35.08,;14.17,-35.08,;13.4,-36.42,;11.86,-36.42,;11.09,-35.08,;9.55,-35.08,;8.78,-36.42,;9.55,-37.75,;11.09,-37.75,;7.24,-36.42,;6.47,-37.75,;7.24,-39.08,;4.93,-37.75,;4.16,-36.42,;4.16,-39.08,;16.38,-36.48,;17.89,-36.82,;19.1,-35.85,;20.44,-36.62,;21.78,-35.85,;21.77,-34.3,;23.1,-33.52,;20.44,-33.54,;19.11,-34.31,)| InChI=1S/C22H34ClN3O/c1-16-15-26(13-11-18-6-7-19(23)14-21(16)18)12-10-17-4-8-20(9-5-17)24-22(27)25(2)3/h6-7,14,16-17,20H,4-5,8-13,15H2,1-3H3,(H,24,27) IDTLNOOYTVGUDL-UHFFFAOYSA-N 50549018 CHEMBL4799863 D(3) dopamine receptor Homo sapiens 0.500000 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549018&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162677036 461679358 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357665 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)CC3(CCCC3)CC2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(78.22,-16.9,;77.88,-18.4,;76.36,-18.74,;75.69,-20.14,;74.15,-20.14,;73.38,-21.48,;71.84,-21.48,;71.07,-20.14,;69.53,-20.14,;68.76,-21.48,;69.53,-22.81,;71.07,-22.81,;67.22,-21.48,;66.46,-22.81,;67.23,-24.15,;64.91,-22.81,;64.15,-21.47,;63.25,-20.22,;61.79,-20.69,;61.78,-22.23,;63.24,-22.71,;64.92,-20.14,;66.46,-20.14,;67.23,-18.81,;76.36,-21.54,;77.87,-21.88,;79.09,-20.91,;80.42,-21.68,;81.76,-20.91,;81.75,-19.36,;83.08,-18.58,;80.42,-18.6,;79.09,-19.37,)| InChI=1S/C28H39ClN2O2/c1-20-19-30(15-11-22-6-7-23(29)16-25(20)22)14-10-21-4-8-24(9-5-21)31-26(32)17-28(18-27(31)33)12-2-3-13-28/h6-7,16,20-21,24H,2-5,8-15,17-19H2,1H3 DTQQYFXMBRLANH-UHFFFAOYSA-N 50549019 CHEMBL4753808 D(3) dopamine receptor Homo sapiens 1.2 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549019&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162653991 461679359 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357666 [H][C@]12C[C@]([H])(C=C1)[C@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@]21[H] |r,wU:12.12,3.3,1.0,35.41,7.8,wD:15.16,28.30,c:5,(34.02,-24.69,;34.03,-23.15,;33.26,-21.65,;34.04,-20.05,;34.03,-18.51,;32.7,-20.82,;32.69,-22.37,;35.37,-20.83,;35.36,-19.29,;36.83,-20.36,;37.31,-18.9,;37.73,-21.61,;39.27,-21.61,;40.03,-20.28,;41.57,-20.28,;42.35,-21.61,;43.88,-21.61,;44.65,-20.28,;46.19,-20.28,;46.86,-21.67,;48.37,-22.01,;49.58,-21.05,;50.91,-21.81,;52.25,-21.05,;52.24,-19.5,;53.57,-18.72,;50.91,-18.73,;49.59,-19.51,;48.37,-18.53,;48.71,-17.03,;46.86,-18.88,;41.57,-22.95,;40.03,-22.95,;36.83,-22.86,;37.3,-24.32,;35.36,-22.38,;35.35,-23.93,)| InChI=1S/C28H35ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h4-7,15,17-18,20-21,23,25-26H,2-3,8-14,16H2,1H3 MJWAVTIYFCPJPE-UHFFFAOYSA-N 50549023 CHEMBL4788140 D(3) dopamine receptor Homo sapiens 6.9 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549023&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162669496 461679363 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357667 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)CCC2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(16.19,-17.03,;15.85,-18.53,;14.33,-18.87,;13.67,-20.28,;12.13,-20.28,;11.36,-21.61,;9.82,-21.61,;9.05,-20.28,;7.51,-20.28,;6.74,-21.61,;7.51,-22.94,;9.05,-22.94,;5.2,-21.61,;4.29,-22.84,;4.76,-24.31,;2.83,-22.37,;2.82,-20.82,;4.29,-20.35,;4.77,-18.89,;14.33,-21.67,;15.84,-22.01,;17.06,-21.04,;18.39,-21.81,;19.73,-21.04,;19.72,-19.49,;21.06,-18.72,;18.39,-18.73,;17.06,-19.5,)| InChI=1S/C23H31ClN2O2/c1-16-15-25(13-11-18-4-5-19(24)14-21(16)18)12-10-17-2-6-20(7-3-17)26-22(27)8-9-23(26)28/h4-5,14,16-17,20H,2-3,6-13,15H2,1H3 ULKPWZSJDGLNAA-UHFFFAOYSA-N 50549024 CHEMBL4779969 D(3) dopamine receptor Homo sapiens 191 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549024&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162662417 461679364 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357668 [H][C@]12CC[C@]([H])(C1)[C@@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@@]21[H] |r,wU:12.12,1.0,4.4,7.8,35.41,wD:15.16,28.30,(63.69,-3.63,;63.7,-5.18,;62.36,-5.95,;62.35,-7.49,;63.69,-8.27,;63.68,-9.82,;62.92,-6.78,;65.02,-7.51,;65.01,-9.05,;66.48,-7.99,;66.96,-9.45,;67.39,-6.74,;68.93,-6.74,;69.69,-5.4,;71.23,-5.41,;72.01,-6.74,;73.54,-6.74,;74.31,-5.41,;75.85,-5.41,;76.52,-6.8,;78.03,-7.14,;79.24,-6.18,;80.57,-6.94,;81.91,-6.17,;81.9,-4.63,;83.23,-3.85,;80.57,-3.86,;79.25,-4.63,;78.03,-3.66,;78.37,-2.16,;76.52,-4.01,;71.23,-8.08,;69.69,-8.08,;66.48,-5.49,;66.97,-4.03,;65.03,-5.96,;65.02,-4.41,)| InChI=1S/C28H37ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h6-7,15,17-18,20-21,23,25-26H,2-5,8-14,16H2,1H3 AIYDXOYEOAYSGJ-UHFFFAOYSA-N 50549025 CHEMBL4784751 D(3) dopamine receptor Homo sapiens 3.3 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549025&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162665485 461679365 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357669 [H][C@@]12CCCC[C@]1([H])C(=O)N([C@H]1CC[C@H](CCN3CCc4ccc(Cl)cc4[C@@H](C)C3)CC1)C2=O |r,wU:11.11,wD:14.15,27.29,1.0,6.7,(5.01,-4.77,;5.03,-6.31,;3.69,-5.55,;2.35,-6.32,;2.36,-7.87,;3.7,-8.64,;5.03,-7.86,;5.02,-9.4,;6.5,-8.34,;6.97,-9.8,;7.4,-7.1,;8.94,-7.1,;9.71,-5.77,;11.25,-5.77,;12.02,-7.1,;13.56,-7.1,;14.33,-5.77,;15.87,-5.77,;16.53,-7.16,;18.04,-7.5,;19.26,-6.53,;20.59,-7.3,;21.93,-6.53,;21.92,-4.98,;23.25,-4.21,;20.59,-4.22,;19.26,-4.99,;18.05,-4.02,;18.39,-2.52,;16.53,-4.37,;11.25,-8.43,;9.71,-8.43,;6.5,-5.85,;6.98,-4.38,)| InChI=1S/C27H37ClN2O2/c1-18-17-29(15-13-20-8-9-21(28)16-25(18)20)14-12-19-6-10-22(11-7-19)30-26(31)23-4-2-3-5-24(23)27(30)32/h8-9,16,18-19,22-24H,2-7,10-15,17H2,1H3 DGWVDYZYSAQNNO-UHFFFAOYSA-N 50549026 CHEMBL4762024 D(3) dopamine receptor Homo sapiens 9.3 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549026&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162659730 461679366 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357670 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)[C@@H]2CCCN2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,15.15,1.0,(77.28,-47.9,;76.94,-49.41,;75.43,-49.75,;74.76,-51.15,;73.22,-51.15,;72.45,-52.49,;70.91,-52.49,;70.14,-51.15,;68.6,-51.15,;67.83,-52.49,;68.6,-53.82,;70.14,-53.82,;66.29,-52.49,;65.52,-53.82,;66.29,-55.15,;63.98,-53.82,;63.07,-55.07,;61.6,-54.59,;61.6,-53.05,;63.07,-52.58,;75.43,-52.55,;76.94,-52.89,;78.15,-51.92,;79.49,-52.69,;80.82,-51.92,;80.82,-50.37,;82.15,-49.59,;79.48,-49.6,;78.16,-50.38,)| InChI=1S/C24H36ClN3O/c1-17-16-28(14-11-19-6-7-20(25)15-22(17)19)13-10-18-4-8-21(9-5-18)27-24(29)23-3-2-12-26-23/h6-7,15,17-18,21,23,26H,2-5,8-14,16H2,1H3,(H,27,29) XWSSRMXCAFXSRM-UHFFFAOYSA-N 50549027 CHEMBL4741673 D(3) dopamine receptor Homo sapiens 9.5 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549027&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162646372 461679367 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357671 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)[C@@H]2CCCO2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,15.15,1.0,(48.38,-48.01,;48.04,-49.51,;46.53,-49.86,;45.86,-51.26,;44.32,-51.26,;43.55,-52.59,;42.01,-52.59,;41.24,-51.26,;39.7,-51.26,;38.93,-52.59,;39.7,-53.93,;41.24,-53.93,;37.39,-52.59,;36.62,-53.93,;37.39,-55.26,;35.08,-53.93,;34.17,-55.18,;32.7,-54.7,;32.7,-53.16,;34.17,-52.69,;46.52,-52.66,;48.03,-53,;49.25,-52.03,;50.58,-52.8,;51.92,-52.03,;51.92,-50.48,;53.25,-49.7,;50.58,-49.71,;49.25,-50.48,)| InChI=1S/C24H35ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h6-7,15,17-18,21,23H,2-5,8-14,16H2,1H3,(H,26,28) ZCTLRJWCRUVTOB-UHFFFAOYSA-N 50549028 CHEMBL4745809 D(3) dopamine receptor Homo sapiens 79 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549028&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162647966 461679368 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357672 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCCCC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.88,-47.34,;18.54,-48.84,;17.03,-49.19,;16.36,-50.59,;14.82,-50.59,;14.05,-51.93,;12.51,-51.93,;11.74,-50.59,;10.2,-50.59,;9.43,-51.92,;10.2,-53.26,;11.74,-53.26,;7.89,-51.92,;7.12,-53.26,;7.89,-54.59,;5.58,-53.26,;4.81,-51.93,;3.27,-51.93,;2.5,-53.26,;3.26,-54.59,;4.81,-54.6,;17.02,-51.99,;18.53,-52.33,;19.75,-51.36,;21.08,-52.13,;22.42,-51.36,;22.42,-49.81,;23.75,-49.03,;21.08,-49.04,;19.75,-49.81,)| InChI=1S/C26H39ClN2O/c1-19-18-29(16-14-21-9-10-23(27)17-25(19)21)15-13-20-7-11-24(12-8-20)28-26(30)22-5-3-2-4-6-22/h9-10,17,19-20,22,24H,2-8,11-16,18H2,1H3,(H,28,30) AMBHQWIFPINWOO-UHFFFAOYSA-N 50549035 CHEMBL4762918 D(3) dopamine receptor Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549035&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162658985 461679375 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357673 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(76.35,-32.33,;76,-33.84,;74.49,-34.18,;73.82,-35.58,;72.28,-35.58,;71.51,-36.92,;69.97,-36.92,;69.2,-35.58,;67.66,-35.58,;66.89,-36.92,;67.66,-38.25,;69.2,-38.25,;65.35,-36.92,;64.58,-38.25,;65.35,-39.58,;63.04,-38.25,;61.7,-37.49,;61.7,-39.03,;74.49,-36.98,;76,-37.32,;77.21,-36.35,;78.55,-37.12,;79.88,-36.35,;79.88,-34.8,;81.21,-34.02,;78.54,-34.03,;77.22,-34.81,)| InChI=1S/C23H33ClN2O/c1-16-15-26(13-11-18-6-7-20(24)14-22(16)18)12-10-17-2-8-21(9-3-17)25-23(27)19-4-5-19/h6-7,14,16-17,19,21H,2-5,8-13,15H2,1H3,(H,25,27) NRCRTBZRIJXRCY-UHFFFAOYSA-N 50549029 CHEMBL4756826 D(3) dopamine receptor Homo sapiens 8.2 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549029&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162655294 461679369 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357674 CCCC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1 |r,wU:6.5,wD:9.9,22.23,(33.19,-39.68,;34.73,-39.68,;35.5,-38.34,;37.04,-38.34,;37.81,-39.68,;37.81,-37.01,;39.35,-37.01,;40.12,-35.68,;41.66,-35.68,;42.43,-37.01,;43.97,-37.01,;44.74,-35.68,;46.28,-35.68,;46.95,-37.07,;48.46,-37.41,;49.67,-36.44,;51.01,-37.21,;52.34,-36.44,;52.34,-34.89,;53.67,-34.12,;51,-34.13,;49.68,-34.9,;48.46,-33.93,;48.8,-32.43,;46.95,-34.28,;41.66,-38.34,;40.12,-38.34,)| InChI=1S/C23H35ClN2O/c1-3-4-23(27)25-21-9-5-18(6-10-21)11-13-26-14-12-19-7-8-20(24)15-22(19)17(2)16-26/h7-8,15,17-18,21H,3-6,9-14,16H2,1-2H3,(H,25,27) WZEVFJPWWRPRRO-UHFFFAOYSA-N 50549036 CHEMBL4761274 D(3) dopamine receptor Homo sapiens 8.1 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549036&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162660216 461679376 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357675 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccco2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(19.71,-32.34,;19.37,-33.84,;17.85,-34.19,;17.18,-35.59,;15.64,-35.59,;14.87,-36.92,;13.33,-36.92,;12.56,-35.59,;11.02,-35.59,;10.25,-36.92,;11.02,-38.26,;12.56,-38.26,;8.71,-36.92,;7.94,-38.26,;8.71,-39.59,;6.4,-38.26,;5.49,-37.02,;4.03,-37.49,;4.03,-39.03,;5.49,-39.51,;17.85,-36.99,;19.36,-37.33,;20.57,-36.36,;21.91,-37.13,;23.25,-36.36,;23.24,-34.81,;24.57,-34.03,;21.91,-34.04,;20.58,-34.81,)| InChI=1S/C24H31ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h2-3,6-7,14-15,17-18,21H,4-5,8-13,16H2,1H3,(H,26,28) KHPOIBBWMVNTMI-UHFFFAOYSA-N 50549020 CHEMBL4780335 D(3) dopamine receptor Homo sapiens 101 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549020&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162662985 461679360 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 51357676 CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)c3cccc(c3Cl)Cl InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28) KPWSJANDNDDRMB-UHFFFAOYSA-N 50443101 Cariprazine::RGH-188::US20250109139, Compound Cariprazine Histamine H1 receptor Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50443101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50443101&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 7RU 7VOD 11154555 194940997 DB06016 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357677 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)CC3(CCCC3)CC2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(78.22,-16.9,;77.88,-18.4,;76.36,-18.74,;75.69,-20.14,;74.15,-20.14,;73.38,-21.48,;71.84,-21.48,;71.07,-20.14,;69.53,-20.14,;68.76,-21.48,;69.53,-22.81,;71.07,-22.81,;67.22,-21.48,;66.46,-22.81,;67.23,-24.15,;64.91,-22.81,;64.15,-21.47,;63.25,-20.22,;61.79,-20.69,;61.78,-22.23,;63.24,-22.71,;64.92,-20.14,;66.46,-20.14,;67.23,-18.81,;76.36,-21.54,;77.87,-21.88,;79.09,-20.91,;80.42,-21.68,;81.76,-20.91,;81.75,-19.36,;83.08,-18.58,;80.42,-18.6,;79.09,-19.37,)| InChI=1S/C28H39ClN2O2/c1-20-19-30(15-11-22-6-7-23(29)16-25(20)22)14-10-21-4-8-24(9-5-21)31-26(32)17-28(18-27(31)33)12-2-3-13-28/h6-7,16,20-21,24H,2-5,8-15,17-19H2,1H3 DTQQYFXMBRLANH-UHFFFAOYSA-N 50549019 CHEMBL4753808 Histamine H1 receptor Homo sapiens 293 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549019&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 162653991 461679359 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357678 [H][C@]12C[C@]([H])(C=C1)[C@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@]21[H] |r,wU:12.12,3.3,1.0,35.41,7.8,wD:15.16,28.30,c:5,(34.02,-24.69,;34.03,-23.15,;33.26,-21.65,;34.04,-20.05,;34.03,-18.51,;32.7,-20.82,;32.69,-22.37,;35.37,-20.83,;35.36,-19.29,;36.83,-20.36,;37.31,-18.9,;37.73,-21.61,;39.27,-21.61,;40.03,-20.28,;41.57,-20.28,;42.35,-21.61,;43.88,-21.61,;44.65,-20.28,;46.19,-20.28,;46.86,-21.67,;48.37,-22.01,;49.58,-21.05,;50.91,-21.81,;52.25,-21.05,;52.24,-19.5,;53.57,-18.72,;50.91,-18.73,;49.59,-19.51,;48.37,-18.53,;48.71,-17.03,;46.86,-18.88,;41.57,-22.95,;40.03,-22.95,;36.83,-22.86,;37.3,-24.32,;35.36,-22.38,;35.35,-23.93,)| InChI=1S/C28H35ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h4-7,15,17-18,20-21,23,25-26H,2-3,8-14,16H2,1H3 MJWAVTIYFCPJPE-UHFFFAOYSA-N 50549023 CHEMBL4788140 Histamine H1 receptor Homo sapiens 312 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549023&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 162669496 461679363 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357679 [H][C@]12CC[C@]([H])(C1)[C@@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@@]21[H] |r,wU:12.12,1.0,4.4,7.8,35.41,wD:15.16,28.30,(63.69,-3.63,;63.7,-5.18,;62.36,-5.95,;62.35,-7.49,;63.69,-8.27,;63.68,-9.82,;62.92,-6.78,;65.02,-7.51,;65.01,-9.05,;66.48,-7.99,;66.96,-9.45,;67.39,-6.74,;68.93,-6.74,;69.69,-5.4,;71.23,-5.41,;72.01,-6.74,;73.54,-6.74,;74.31,-5.41,;75.85,-5.41,;76.52,-6.8,;78.03,-7.14,;79.24,-6.18,;80.57,-6.94,;81.91,-6.17,;81.9,-4.63,;83.23,-3.85,;80.57,-3.86,;79.25,-4.63,;78.03,-3.66,;78.37,-2.16,;76.52,-4.01,;71.23,-8.08,;69.69,-8.08,;66.48,-5.49,;66.97,-4.03,;65.03,-5.96,;65.02,-4.41,)| InChI=1S/C28H37ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h6-7,15,17-18,20-21,23,25-26H,2-5,8-14,16H2,1H3 AIYDXOYEOAYSGJ-UHFFFAOYSA-N 50549025 CHEMBL4784751 Histamine H1 receptor Homo sapiens 195 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549025&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 162665485 461679365 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357680 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccco2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(19.71,-32.34,;19.37,-33.84,;17.85,-34.19,;17.18,-35.59,;15.64,-35.59,;14.87,-36.92,;13.33,-36.92,;12.56,-35.59,;11.02,-35.59,;10.25,-36.92,;11.02,-38.26,;12.56,-38.26,;8.71,-36.92,;7.94,-38.26,;8.71,-39.59,;6.4,-38.26,;5.49,-37.02,;4.03,-37.49,;4.03,-39.03,;5.49,-39.51,;17.85,-36.99,;19.36,-37.33,;20.57,-36.36,;21.91,-37.13,;23.25,-36.36,;23.24,-34.81,;24.57,-34.03,;21.91,-34.04,;20.58,-34.81,)| InChI=1S/C24H31ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h2-3,6-7,14-15,17-18,21H,4-5,8-13,16H2,1H3,(H,26,28) KHPOIBBWMVNTMI-UHFFFAOYSA-N 50549020 CHEMBL4780335 Histamine H1 receptor Homo sapiens 82 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549020&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 162662985 461679360 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357681 CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)c3cccc(c3Cl)Cl InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28) KPWSJANDNDDRMB-UHFFFAOYSA-N 50443101 Cariprazine::RGH-188::US20250109139, Compound Cariprazine D(2) dopamine receptor Homo sapiens 0.490000 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50443101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50443101&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 7RU 7VOD 11154555 194940997 DB06016 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357682 C[C@@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)C)CCc2ccc(Cl)cc12 |r,wU:9.12,1.0,wD:6.5,(76.3,-2.9,;75.95,-4.4,;74.44,-4.74,;73.77,-6.14,;72.23,-6.14,;71.46,-7.48,;69.92,-7.48,;69.15,-6.14,;67.61,-6.14,;66.84,-7.48,;67.61,-8.81,;69.15,-8.81,;65.3,-7.48,;64.53,-8.81,;65.3,-10.14,;62.99,-8.81,;62.22,-7.48,;62.22,-10.14,;74.44,-7.54,;75.95,-7.88,;77.16,-6.91,;78.5,-7.68,;79.83,-6.91,;79.83,-5.36,;81.16,-4.58,;78.49,-4.6,;77.17,-5.37,)| InChI=1S/C22H34ClN3O/c1-16-15-26(13-11-18-6-7-19(23)14-21(16)18)12-10-17-4-8-20(9-5-17)24-22(27)25(2)3/h6-7,14,16-17,20H,4-5,8-13,15H2,1-3H3,(H,24,27) IDTLNOOYTVGUDL-UHFFFAOYSA-N 50549030 CHEMBL4779912 D(2) dopamine receptor Homo sapiens 291 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549030&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162663054 461679370 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357683 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)c2ccccc2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.74,-2.02,;18.39,-3.52,;16.88,-3.86,;16.21,-5.27,;14.67,-5.27,;13.9,-6.6,;12.36,-6.6,;11.59,-5.27,;10.05,-5.26,;9.28,-6.6,;10.05,-7.93,;11.59,-7.93,;7.74,-6.6,;6.97,-7.93,;7.74,-9.27,;5.43,-7.93,;4.66,-6.6,;4.66,-9.27,;3.12,-9.26,;2.35,-10.59,;3.12,-11.93,;4.67,-11.92,;5.43,-10.59,;16.88,-6.66,;18.39,-7,;19.6,-6.03,;20.94,-6.8,;22.27,-6.03,;22.27,-4.48,;23.6,-3.71,;20.93,-3.72,;19.61,-4.49,)| InChI=1S/C27H36ClN3O/c1-20-19-31(17-15-22-10-11-23(28)18-26(20)22)16-14-21-8-12-24(13-9-21)29-27(32)30(2)25-6-4-3-5-7-25/h3-7,10-11,18,20-21,24H,8-9,12-17,19H2,1-2H3,(H,29,32) KAXUQVAHOIHHMX-UHFFFAOYSA-N 50549031 CHEMBL4755563 D(2) dopamine receptor Homo sapiens 189 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549031&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162655913 461679371 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357684 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)Nc2ccccc2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(80.06,-46.54,;79.71,-48.04,;78.2,-48.38,;77.53,-49.79,;75.99,-49.79,;75.22,-51.12,;73.68,-51.12,;72.91,-49.78,;71.37,-49.78,;70.6,-51.12,;71.37,-52.45,;72.91,-52.45,;69.06,-51.12,;68.29,-52.45,;69.06,-53.79,;66.75,-52.45,;65.98,-53.79,;64.44,-53.78,;63.67,-55.11,;64.44,-56.45,;65.99,-56.44,;66.75,-55.11,;78.2,-51.18,;79.71,-51.52,;80.92,-50.55,;82.26,-51.32,;83.59,-50.55,;83.59,-49,;84.92,-48.23,;82.25,-48.24,;80.93,-49.01,)| InChI=1S/C26H34ClN3O/c1-19-18-30(16-14-21-9-10-22(27)17-25(19)21)15-13-20-7-11-24(12-8-20)29-26(31)28-23-5-3-2-4-6-23/h2-6,9-10,17,19-20,24H,7-8,11-16,18H2,1H3,(H2,28,29,31) DCIOHCJFMCIMPE-UHFFFAOYSA-N 50549032 CHEMBL4759975 D(2) dopamine receptor Homo sapiens 2.8 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549032&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162658416 461679372 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357685 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N2CCCC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(48.42,-47.98,;48.08,-49.48,;46.56,-49.83,;45.89,-51.23,;44.36,-51.23,;43.58,-52.56,;42.04,-52.56,;41.28,-51.23,;39.74,-51.23,;38.97,-52.56,;39.74,-53.9,;41.27,-53.9,;37.43,-52.56,;36.66,-53.9,;37.42,-55.23,;35.12,-53.9,;34.2,-52.65,;32.74,-53.13,;32.74,-54.67,;34.2,-55.15,;46.56,-52.63,;48.07,-52.97,;49.29,-52,;50.62,-52.77,;51.96,-52,;51.95,-50.44,;53.28,-49.67,;50.62,-49.68,;49.29,-50.45,)| InChI=1S/C24H36ClN3O/c1-18-17-27(15-11-20-6-7-21(25)16-23(18)20)14-10-19-4-8-22(9-5-19)26-24(29)28-12-2-3-13-28/h6-7,16,18-19,22H,2-5,8-15,17H2,1H3,(H,26,29) ORDRIDLDACAQJO-UHFFFAOYSA-N 50549021 CHEMBL4797996 D(2) dopamine receptor Homo sapiens 6.3 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549021&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162674746 461679361 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357686 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N2CCOCC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.81,-48,;18.47,-49.5,;16.96,-49.85,;16.29,-51.25,;14.75,-51.25,;13.98,-52.58,;12.44,-52.58,;11.67,-51.25,;10.13,-51.25,;9.36,-52.58,;10.13,-53.91,;11.67,-53.91,;7.82,-52.58,;7.05,-53.91,;7.82,-55.25,;5.51,-53.91,;4.74,-55.25,;3.2,-55.25,;2.43,-53.91,;3.2,-52.58,;4.74,-52.58,;16.95,-52.64,;18.47,-52.98,;19.68,-52.01,;21.01,-52.78,;22.35,-52.01,;22.35,-50.46,;23.68,-49.69,;21.01,-49.7,;19.69,-50.47,)| InChI=1S/C24H36ClN3O2/c1-18-17-27(11-9-20-4-5-21(25)16-23(18)20)10-8-19-2-6-22(7-3-19)26-24(29)28-12-14-30-15-13-28/h4-5,16,18-19,22H,2-3,6-15,17H2,1H3,(H,26,29) UNEYERITNKRLJR-UHFFFAOYSA-N 50549033 CHEMBL4741702 D(2) dopamine receptor Homo sapiens 2.9 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549033&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162646791 461679373 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357687 CCN(CC)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1 |r,wU:8.7,wD:11.11,24.25,(63.55,-38.58,;65.09,-38.58,;65.86,-37.25,;65.09,-35.91,;63.55,-35.91,;67.4,-37.25,;68.17,-38.58,;68.17,-35.91,;69.71,-35.91,;70.48,-34.58,;72.02,-34.58,;72.79,-35.91,;74.33,-35.91,;75.1,-34.58,;76.64,-34.58,;77.31,-35.98,;78.82,-36.32,;80.04,-35.35,;81.37,-36.12,;82.71,-35.35,;82.7,-33.79,;84.03,-33.02,;81.37,-33.03,;80.04,-33.8,;78.83,-32.83,;79.17,-31.33,;77.31,-33.18,;72.02,-37.25,;70.48,-37.25,)| InChI=1S/C24H38ClN3O/c1-4-28(5-2)24(29)26-22-10-6-19(7-11-22)12-14-27-15-13-20-8-9-21(25)16-23(20)18(3)17-27/h8-9,16,18-19,22H,4-7,10-15,17H2,1-3H3,(H,26,29) CRTXNNNIYVQHEB-UHFFFAOYSA-N 50549034 CHEMBL4743651 D(2) dopamine receptor Homo sapiens 91 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549034&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162645987 461679374 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357688 CCN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1 |r,wU:7.6,wD:10.10,23.24,(32.92,-39.33,;34.46,-39.33,;35.23,-38,;34.46,-36.67,;36.77,-38,;37.54,-39.33,;37.54,-36.67,;39.08,-36.67,;39.85,-35.33,;41.39,-35.33,;42.16,-36.67,;43.7,-36.67,;44.47,-35.33,;46.01,-35.33,;46.67,-36.73,;48.18,-37.07,;49.4,-36.1,;50.73,-36.87,;52.07,-36.1,;52.07,-34.55,;53.4,-33.77,;50.73,-33.79,;49.4,-34.56,;48.19,-33.59,;48.53,-32.09,;46.68,-33.93,;41.39,-38,;39.85,-38,)| InChI=1S/C23H36ClN3O/c1-4-26(3)23(28)25-21-9-5-18(6-10-21)11-13-27-14-12-19-7-8-20(24)15-22(19)17(2)16-27/h7-8,15,17-18,21H,4-6,9-14,16H2,1-3H3,(H,25,28) HXHYBBJDNMJVBF-UHFFFAOYSA-N 50549022 CHEMBL4750939 D(2) dopamine receptor Homo sapiens 24 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549022&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162652001 461679362 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357689 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)N(C)C)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.24,-31.84,;17.89,-33.34,;16.38,-33.68,;15.71,-35.08,;14.17,-35.08,;13.4,-36.42,;11.86,-36.42,;11.09,-35.08,;9.55,-35.08,;8.78,-36.42,;9.55,-37.75,;11.09,-37.75,;7.24,-36.42,;6.47,-37.75,;7.24,-39.08,;4.93,-37.75,;4.16,-36.42,;4.16,-39.08,;16.38,-36.48,;17.89,-36.82,;19.1,-35.85,;20.44,-36.62,;21.78,-35.85,;21.77,-34.3,;23.1,-33.52,;20.44,-33.54,;19.11,-34.31,)| InChI=1S/C22H34ClN3O/c1-16-15-26(13-11-18-6-7-19(23)14-21(16)18)12-10-17-4-8-20(9-5-17)24-22(27)25(2)3/h6-7,14,16-17,20H,4-5,8-13,15H2,1-3H3,(H,24,27) IDTLNOOYTVGUDL-UHFFFAOYSA-N 50549018 CHEMBL4799863 D(2) dopamine receptor Homo sapiens 5.9 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549018&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162677036 461679358 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357690 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)CC3(CCCC3)CC2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(78.22,-16.9,;77.88,-18.4,;76.36,-18.74,;75.69,-20.14,;74.15,-20.14,;73.38,-21.48,;71.84,-21.48,;71.07,-20.14,;69.53,-20.14,;68.76,-21.48,;69.53,-22.81,;71.07,-22.81,;67.22,-21.48,;66.46,-22.81,;67.23,-24.15,;64.91,-22.81,;64.15,-21.47,;63.25,-20.22,;61.79,-20.69,;61.78,-22.23,;63.24,-22.71,;64.92,-20.14,;66.46,-20.14,;67.23,-18.81,;76.36,-21.54,;77.87,-21.88,;79.09,-20.91,;80.42,-21.68,;81.76,-20.91,;81.75,-19.36,;83.08,-18.58,;80.42,-18.6,;79.09,-19.37,)| InChI=1S/C28H39ClN2O2/c1-20-19-30(15-11-22-6-7-23(29)16-25(20)22)14-10-21-4-8-24(9-5-21)31-26(32)17-28(18-27(31)33)12-2-3-13-28/h6-7,16,20-21,24H,2-5,8-15,17-19H2,1H3 DTQQYFXMBRLANH-UHFFFAOYSA-N 50549019 CHEMBL4753808 D(2) dopamine receptor Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549019&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162653991 461679359 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357691 [H][C@]12C[C@]([H])(C=C1)[C@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@]21[H] |r,wU:12.12,3.3,1.0,35.41,7.8,wD:15.16,28.30,c:5,(34.02,-24.69,;34.03,-23.15,;33.26,-21.65,;34.04,-20.05,;34.03,-18.51,;32.7,-20.82,;32.69,-22.37,;35.37,-20.83,;35.36,-19.29,;36.83,-20.36,;37.31,-18.9,;37.73,-21.61,;39.27,-21.61,;40.03,-20.28,;41.57,-20.28,;42.35,-21.61,;43.88,-21.61,;44.65,-20.28,;46.19,-20.28,;46.86,-21.67,;48.37,-22.01,;49.58,-21.05,;50.91,-21.81,;52.25,-21.05,;52.24,-19.5,;53.57,-18.72,;50.91,-18.73,;49.59,-19.51,;48.37,-18.53,;48.71,-17.03,;46.86,-18.88,;41.57,-22.95,;40.03,-22.95,;36.83,-22.86,;37.3,-24.32,;35.36,-22.38,;35.35,-23.93,)| InChI=1S/C28H35ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h4-7,15,17-18,20-21,23,25-26H,2-3,8-14,16H2,1H3 MJWAVTIYFCPJPE-UHFFFAOYSA-N 50549023 CHEMBL4788140 D(2) dopamine receptor Homo sapiens 44 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549023&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162669496 461679363 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357692 [H][C@]12CC[C@]([H])(C1)[C@@]1([H])C(=O)N([C@H]3CC[C@H](CCN4CCc5ccc(Cl)cc5[C@@H](C)C4)CC3)C(=O)[C@@]21[H] |r,wU:12.12,1.0,4.4,7.8,35.41,wD:15.16,28.30,(63.69,-3.63,;63.7,-5.18,;62.36,-5.95,;62.35,-7.49,;63.69,-8.27,;63.68,-9.82,;62.92,-6.78,;65.02,-7.51,;65.01,-9.05,;66.48,-7.99,;66.96,-9.45,;67.39,-6.74,;68.93,-6.74,;69.69,-5.4,;71.23,-5.41,;72.01,-6.74,;73.54,-6.74,;74.31,-5.41,;75.85,-5.41,;76.52,-6.8,;78.03,-7.14,;79.24,-6.18,;80.57,-6.94,;81.91,-6.17,;81.9,-4.63,;83.23,-3.85,;80.57,-3.86,;79.25,-4.63,;78.03,-3.66,;78.37,-2.16,;76.52,-4.01,;71.23,-8.08,;69.69,-8.08,;66.48,-5.49,;66.97,-4.03,;65.03,-5.96,;65.02,-4.41,)| InChI=1S/C28H37ClN2O2/c1-17-16-30(13-11-19-6-7-22(29)15-24(17)19)12-10-18-2-8-23(9-3-18)31-27(32)25-20-4-5-21(14-20)26(25)28(31)33/h6-7,15,17-18,20-21,23,25-26H,2-5,8-14,16H2,1H3 AIYDXOYEOAYSGJ-UHFFFAOYSA-N 50549025 CHEMBL4784751 D(2) dopamine receptor Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549025&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162665485 461679365 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357693 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)N2C(=O)c3ccccc3C2=O)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(48.59,-2.09,;48.24,-3.59,;46.73,-3.93,;46.06,-5.34,;44.52,-5.34,;43.75,-6.67,;42.21,-6.67,;41.44,-5.34,;39.9,-5.34,;39.13,-6.67,;39.9,-8,;41.44,-8,;37.59,-6.67,;36.69,-7.91,;37.17,-9.38,;35.22,-7.44,;33.9,-8.2,;32.57,-7.44,;32.57,-5.9,;33.9,-5.13,;35.23,-5.9,;36.69,-5.42,;37.17,-3.96,;46.73,-6.73,;48.24,-7.07,;49.45,-6.1,;50.79,-6.87,;52.13,-6.1,;52.12,-4.55,;53.45,-3.78,;50.78,-3.79,;49.46,-4.56,)| InChI=1S/C27H31ClN2O2/c1-18-17-29(15-13-20-8-9-21(28)16-25(18)20)14-12-19-6-10-22(11-7-19)30-26(31)23-4-2-3-5-24(23)27(30)32/h2-5,8-9,16,18-19,22H,6-7,10-15,17H2,1H3 ADVQAEICXAHZOY-UHFFFAOYSA-N 50549037 CHEMBL4752414 D(2) dopamine receptor Homo sapiens 5.8 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549037&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162652984 461679377 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357694 [H][C@@]12CCCC[C@]1([H])C(=O)N([C@H]1CC[C@H](CCN3CCc4ccc(Cl)cc4[C@@H](C)C3)CC1)C2=O |r,wU:11.11,wD:14.15,27.29,1.0,6.7,(5.01,-4.77,;5.03,-6.31,;3.69,-5.55,;2.35,-6.32,;2.36,-7.87,;3.7,-8.64,;5.03,-7.86,;5.02,-9.4,;6.5,-8.34,;6.97,-9.8,;7.4,-7.1,;8.94,-7.1,;9.71,-5.77,;11.25,-5.77,;12.02,-7.1,;13.56,-7.1,;14.33,-5.77,;15.87,-5.77,;16.53,-7.16,;18.04,-7.5,;19.26,-6.53,;20.59,-7.3,;21.93,-6.53,;21.92,-4.98,;23.25,-4.21,;20.59,-4.22,;19.26,-4.99,;18.05,-4.02,;18.39,-2.52,;16.53,-4.37,;11.25,-8.43,;9.71,-8.43,;6.5,-5.85,;6.98,-4.38,)| InChI=1S/C27H37ClN2O2/c1-18-17-29(15-13-20-8-9-21(28)16-25(18)20)14-12-19-6-10-22(11-7-19)30-26(31)23-4-2-3-5-24(23)27(30)32/h8-9,16,18-19,22-24H,2-7,10-15,17H2,1H3 DGWVDYZYSAQNNO-UHFFFAOYSA-N 50549026 CHEMBL4762024 D(2) dopamine receptor Homo sapiens 14 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549026&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162659730 461679366 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357695 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)[C@@H]2CCCN2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,15.15,1.0,(77.28,-47.9,;76.94,-49.41,;75.43,-49.75,;74.76,-51.15,;73.22,-51.15,;72.45,-52.49,;70.91,-52.49,;70.14,-51.15,;68.6,-51.15,;67.83,-52.49,;68.6,-53.82,;70.14,-53.82,;66.29,-52.49,;65.52,-53.82,;66.29,-55.15,;63.98,-53.82,;63.07,-55.07,;61.6,-54.59,;61.6,-53.05,;63.07,-52.58,;75.43,-52.55,;76.94,-52.89,;78.15,-51.92,;79.49,-52.69,;80.82,-51.92,;80.82,-50.37,;82.15,-49.59,;79.48,-49.6,;78.16,-50.38,)| InChI=1S/C24H36ClN3O/c1-17-16-28(14-11-19-6-7-20(25)15-22(17)19)13-10-18-4-8-21(9-5-18)27-24(29)23-3-2-12-26-23/h6-7,15,17-18,21,23,26H,2-5,8-14,16H2,1H3,(H,27,29) XWSSRMXCAFXSRM-UHFFFAOYSA-N 50549027 CHEMBL4741673 D(2) dopamine receptor Homo sapiens 25 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549027&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162646372 461679367 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357696 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)[C@@H]2CCCO2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,15.15,1.0,(48.38,-48.01,;48.04,-49.51,;46.53,-49.86,;45.86,-51.26,;44.32,-51.26,;43.55,-52.59,;42.01,-52.59,;41.24,-51.26,;39.7,-51.26,;38.93,-52.59,;39.7,-53.93,;41.24,-53.93,;37.39,-52.59,;36.62,-53.93,;37.39,-55.26,;35.08,-53.93,;34.17,-55.18,;32.7,-54.7,;32.7,-53.16,;34.17,-52.69,;46.52,-52.66,;48.03,-53,;49.25,-52.03,;50.58,-52.8,;51.92,-52.03,;51.92,-50.48,;53.25,-49.7,;50.58,-49.71,;49.25,-50.48,)| InChI=1S/C24H35ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h6-7,15,17-18,21,23H,2-5,8-14,16H2,1H3,(H,26,28) ZCTLRJWCRUVTOB-UHFFFAOYSA-N 50549028 CHEMBL4745809 D(2) dopamine receptor Homo sapiens 21 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549028&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162647966 461679368 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357697 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCCCC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(18.88,-47.34,;18.54,-48.84,;17.03,-49.19,;16.36,-50.59,;14.82,-50.59,;14.05,-51.93,;12.51,-51.93,;11.74,-50.59,;10.2,-50.59,;9.43,-51.92,;10.2,-53.26,;11.74,-53.26,;7.89,-51.92,;7.12,-53.26,;7.89,-54.59,;5.58,-53.26,;4.81,-51.93,;3.27,-51.93,;2.5,-53.26,;3.26,-54.59,;4.81,-54.6,;17.02,-51.99,;18.53,-52.33,;19.75,-51.36,;21.08,-52.13,;22.42,-51.36,;22.42,-49.81,;23.75,-49.03,;21.08,-49.04,;19.75,-49.81,)| InChI=1S/C26H39ClN2O/c1-19-18-29(16-14-21-9-10-23(27)17-25(19)21)15-13-20-7-11-24(12-8-20)28-26(30)22-5-3-2-4-6-22/h9-10,17,19-20,22,24H,2-8,11-16,18H2,1H3,(H,28,30) AMBHQWIFPINWOO-UHFFFAOYSA-N 50549035 CHEMBL4762918 D(2) dopamine receptor Homo sapiens 99 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549035&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162658985 461679375 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357698 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CC2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(76.35,-32.33,;76,-33.84,;74.49,-34.18,;73.82,-35.58,;72.28,-35.58,;71.51,-36.92,;69.97,-36.92,;69.2,-35.58,;67.66,-35.58,;66.89,-36.92,;67.66,-38.25,;69.2,-38.25,;65.35,-36.92,;64.58,-38.25,;65.35,-39.58,;63.04,-38.25,;61.7,-37.49,;61.7,-39.03,;74.49,-36.98,;76,-37.32,;77.21,-36.35,;78.55,-37.12,;79.88,-36.35,;79.88,-34.8,;81.21,-34.02,;78.54,-34.03,;77.22,-34.81,)| InChI=1S/C23H33ClN2O/c1-16-15-26(13-11-18-6-7-20(24)14-22(16)18)12-10-17-2-8-21(9-3-17)25-23(27)19-4-5-19/h6-7,14,16-17,19,21H,2-5,8-13,15H2,1H3,(H,25,27) NRCRTBZRIJXRCY-UHFFFAOYSA-N 50549029 CHEMBL4756826 D(2) dopamine receptor Homo sapiens 9.8 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549029&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162655294 461679369 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357699 CCCC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1 |r,wU:6.5,wD:9.9,22.23,(33.19,-39.68,;34.73,-39.68,;35.5,-38.34,;37.04,-38.34,;37.81,-39.68,;37.81,-37.01,;39.35,-37.01,;40.12,-35.68,;41.66,-35.68,;42.43,-37.01,;43.97,-37.01,;44.74,-35.68,;46.28,-35.68,;46.95,-37.07,;48.46,-37.41,;49.67,-36.44,;51.01,-37.21,;52.34,-36.44,;52.34,-34.89,;53.67,-34.12,;51,-34.13,;49.68,-34.9,;48.46,-33.93,;48.8,-32.43,;46.95,-34.28,;41.66,-38.34,;40.12,-38.34,)| InChI=1S/C23H35ClN2O/c1-3-4-23(27)25-21-9-5-18(6-10-21)11-13-26-14-12-19-7-8-20(24)15-22(19)17(2)16-26/h7-8,15,17-18,21H,3-6,9-14,16H2,1-2H3,(H,25,27) WZEVFJPWWRPRRO-UHFFFAOYSA-N 50549036 CHEMBL4761274 D(2) dopamine receptor Homo sapiens 84 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549036&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162660216 461679376 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357700 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccco2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(19.71,-32.34,;19.37,-33.84,;17.85,-34.19,;17.18,-35.59,;15.64,-35.59,;14.87,-36.92,;13.33,-36.92,;12.56,-35.59,;11.02,-35.59,;10.25,-36.92,;11.02,-38.26,;12.56,-38.26,;8.71,-36.92,;7.94,-38.26,;8.71,-39.59,;6.4,-38.26,;5.49,-37.02,;4.03,-37.49,;4.03,-39.03,;5.49,-39.51,;17.85,-36.99,;19.36,-37.33,;20.57,-36.36,;21.91,-37.13,;23.25,-36.36,;23.24,-34.81,;24.57,-34.03,;21.91,-34.04,;20.58,-34.81,)| InChI=1S/C24H31ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h2-3,6-7,14-15,17-18,21H,4-5,8-13,16H2,1H3,(H,26,28) KHPOIBBWMVNTMI-UHFFFAOYSA-N 50549020 CHEMBL4780335 D(2) dopamine receptor Homo sapiens 94 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549020&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 162662985 461679360 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 51357701 CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)c3cccc(c3Cl)Cl InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28) KPWSJANDNDDRMB-UHFFFAOYSA-N 50443101 Cariprazine::RGH-188::US20250109139, Compound Cariprazine Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Rattus norvegicus 155 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50443101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000229&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50443101&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 7RU 11154555 194940997 DB06016 3 MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF Alpha-1B adrenergic receptor ADA1B_RAT P15823 Q63215 MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV Alpha-1A adrenergic receptor ADA1A_RAT P43140 MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI Alpha-1D adrenergic receptor ADA1D_RAT P23944 Q71UM4 51357702 C[C@H]1CN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccco2)CCc2ccc(Cl)cc12 |r,wU:9.12,wD:6.5,1.0,(19.71,-32.34,;19.37,-33.84,;17.85,-34.19,;17.18,-35.59,;15.64,-35.59,;14.87,-36.92,;13.33,-36.92,;12.56,-35.59,;11.02,-35.59,;10.25,-36.92,;11.02,-38.26,;12.56,-38.26,;8.71,-36.92,;7.94,-38.26,;8.71,-39.59,;6.4,-38.26,;5.49,-37.02,;4.03,-37.49,;4.03,-39.03,;5.49,-39.51,;17.85,-36.99,;19.36,-37.33,;20.57,-36.36,;21.91,-37.13,;23.25,-36.36,;23.24,-34.81,;24.57,-34.03,;21.91,-34.04,;20.58,-34.81,)| InChI=1S/C24H31ClN2O2/c1-17-16-27(13-11-19-6-7-20(25)15-22(17)19)12-10-18-4-8-21(9-5-18)26-24(28)23-3-2-14-29-23/h2-3,6-7,14-15,17-18,21H,4-5,8-13,16H2,1H3,(H,26,28) KHPOIBBWMVNTMI-UHFFFAOYSA-N 50549020 CHEMBL4780335 Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Rattus norvegicus 51 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000229&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549020&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162662985 461679360 3 MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF Alpha-1B adrenergic receptor ADA1B_RAT P15823 Q63215 MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV Alpha-1A adrenergic receptor ADA1A_RAT P43140 MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI Alpha-1D adrenergic receptor ADA1D_RAT P23944 Q71UM4 51357703 [H][C@]12CN(C)C[C@]1([H])c1cc(Cl)ccc1Oc1ccccc21 |r| InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3 VSWBSWWIRNCQIJ-UHFFFAOYSA-N 50549038 CHEMBL504548::CHEBI:71257 Histamine H1 receptor Homo sapiens 1.000000 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549038&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 163091 461679378 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357704 c1cc(c(c(c1)Cl)Cl)N2CCN(CC2)CCCCOc3ccc4c(c3)NC(=O)CC4 InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29) CEUORZQYGODEFX-UHFFFAOYSA-N 50130293 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one::CHEMBL1112::ARIPIPRAZOLE::US9018213, aripprazole::US9156822, Aripiprazole::US10174011, aripiprazole::US10752588, Compound Aripiprazole::US11498896, Compound Aripiprazole::US20240124456, Compound Aripiprazole::US20250109139, Compound Aripiprazole Histamine H1 receptor Homo sapiens 61 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50130293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50130293&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 9SC 6A7P,7E2Z,7VOE,7VR9,7WKZ 60795 104021727 CHEMBL1112 DB01238 C12564 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357705 c1ccc2c(c1)c(ns2)N3CCN(CC3)CCc4cc5c(cc4Cl)NC(=O)C5 InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27) MVWVFYHBGMAFLY-UHFFFAOYSA-N 50048803 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one::5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole)::GEODON::5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone)::ZIPRASIDONE HYDROCHLORIDE::5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one::CHEMBL708::ZIPRASIDONE Histamine H1 receptor Homo sapiens 50 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50048803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50048803&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search XEF 8WTY 60854 103979184 CHEMBL708 DB00246 C07568 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357706 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12 |t:13| InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2 URKOMYMAXPYINW-UHFFFAOYSA-N 50095890 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol::2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol::CHEMBL716::QUETIAPINE Histamine H1 receptor Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50095890 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50095890&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 5002 103993497 CHEMBL716 DB01224 C07397 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357707 CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12 |t:8| InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 KVWDHTXUZHCGIO-UHFFFAOYSA-N 35254 CHEMBL715::2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine::Olansek::Zyprexa::US8802672, Olanzapine::olanzapine Histamine H1 receptor Homo sapiens 7.0 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35254&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 4585 85753333 CHEMBL715 DB00334 C07322 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357708 CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)c4c5ccc(cc5on4)F InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 RAPZEAPATHNIPO-UHFFFAOYSA-N 50001885 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one(risperidone)::US8802672, Risperidone::2-(2-(4-(benzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-7,8,9,9a-tetrahydro-1H-pyrido[1,2-a]pyrimidin-4(6H)-one::2-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-6,7,8,8a-tetrahydro-5H-naphthalen-1-one::1-(2-Allyl-phenoxy)-3-isopropylamino-propan-2-ol::(risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one::RISPERDAL::R 64 766::3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one::CHEMBL85::3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one::3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (risperidone)::3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone)::5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-methyl-1,3-dihydro-indol-2-one(Norastemizole)::RISPERIDONE::US10167256, Risperidone::US10174011, risperidone::US10259786, Risperidone::US10501452, Compound risperidone::WO2023288027, Cmpd Risperidone Histamine H1 receptor Homo sapiens 20 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50001885 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50001885&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 8NU 6A93,6CM4 5073 103916252 CHEMBL85 DB00734 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 51357709 [H][C@]12CN(C)C[C@]1([H])c1cc(Cl)ccc1Oc1ccccc21 |r| InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3 VSWBSWWIRNCQIJ-UHFFFAOYSA-N 50549038 CHEMBL504548::CHEBI:71257 Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Homo sapiens 1.2 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50549038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000717&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50549038&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 163091 461679378 3 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 51357710 c1cc(c(c(c1)Cl)Cl)N2CCN(CC2)CCCCOc3ccc4c(c3)NC(=O)CC4 InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29) CEUORZQYGODEFX-UHFFFAOYSA-N 50130293 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one::CHEMBL1112::ARIPIPRAZOLE::US9018213, aripprazole::US9156822, Aripiprazole::US10174011, aripiprazole::US10752588, Compound Aripiprazole::US11498896, Compound Aripiprazole::US20240124456, Compound Aripiprazole::US20250109139, Compound Aripiprazole Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Homo sapiens 57 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50130293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000717&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50130293&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 9SC 60795 104021727 CHEMBL1112 DB01238 C12564 3 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 51357711 c1ccc2c(c1)c(ns2)N3CCN(CC3)CCc4cc5c(cc4Cl)NC(=O)C5 InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27) MVWVFYHBGMAFLY-UHFFFAOYSA-N 50048803 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one::5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole)::GEODON::5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone)::ZIPRASIDONE HYDROCHLORIDE::5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one::CHEMBL708::ZIPRASIDONE Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50048803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000717&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50048803&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search XEF 60854 103979184 CHEMBL708 DB00246 C07568 3 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 51357712 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12 |t:13| InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2 URKOMYMAXPYINW-UHFFFAOYSA-N 50095890 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol::2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol::CHEMBL716::QUETIAPINE Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Homo sapiens 7.0 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50095890 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000717&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50095890&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 5002 103993497 CHEMBL716 DB01224 C07397 3 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 51357713 CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12 |t:8| InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 KVWDHTXUZHCGIO-UHFFFAOYSA-N 35254 CHEMBL715::2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine::Olansek::Zyprexa::US8802672, Olanzapine::olanzapine Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Homo sapiens 19 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000717&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35254&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 4585 85753333 CHEMBL715 DB00334 C07322 3 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0 51357714 CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)c4c5ccc(cc5on4)F InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 RAPZEAPATHNIPO-UHFFFAOYSA-N 50001885 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one(risperidone)::US8802672, Risperidone::2-(2-(4-(benzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-7,8,9,9a-tetrahydro-1H-pyrido[1,2-a]pyrimidin-4(6H)-one::2-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-6,7,8,8a-tetrahydro-5H-naphthalen-1-one::1-(2-Allyl-phenoxy)-3-isopropylamino-propan-2-ol::(risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one::RISPERDAL::R 64 766::3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one::CHEMBL85::3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one::3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (risperidone)::3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone)::5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-methyl-1,3-dihydro-indol-2-one(Norastemizole)::RISPERIDONE::US10167256, Risperidone::US10174011, risperidone::US10259786, Risperidone::US10501452, Compound risperidone::WO2023288027, Cmpd Risperidone Alpha-1A/Alpha-1B/Alpha-1D adrenergic receptor Homo sapiens 0.700000 ChEMBL 10.1016/j.bmcl.2020.127681 10.7270/Q2BZ69PB 33189775 Xu, JW; Qi, YL; Wu, JW; Yuan, RX; Chen, XW; Li, JQ 1/1/2021 3/23/2022 Shanghai Institute of Pharmaceutical Industry http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50001885 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50000717&target=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50001885&enzyme=Alpha-1A%2FAlpha-1B%2FAlpha-1D+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 8NU 5073 103916252 CHEMBL85 DB00734 3 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF Alpha-1B adrenergic receptor ADA1B_HUMAN P35368 B0LPE1 MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI Alpha-1D adrenergic receptor ADA1D_HUMAN P25100 Q9NPY0